What hematological side effects, such as hemolytic anemia or leukopenia, might be associated with methyldopa therapy and what monitoring and diagnostic steps are necessary for early detection?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa can cause hemolytic anemia and leukopenia. Monitor CBC regularly; assess for anemia and leukocyte count. Coombs test may diagnose hemolytic anemia early.